| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/PL00014051 |
| P698 | PubMed publication ID | 10950149 |
| P50 | author | Toshiaki Koda | Q60315546 |
| P2093 | author name string | M Sato | |
| M Sekimoto | |||
| A Ohta | |||
| H Kitamura | |||
| S Nishimura | |||
| T Nishimura | |||
| K Iwakabe | |||
| M Nakui | |||
| P921 | main subject | immunology | Q101929 |
| P304 | page(s) | S52-61 | |
| P577 | publication date | 2000-01-01 | |
| P1433 | published in | Cancer Chemotherapy and Pharmacology | Q326137 |
| P1476 | title | The critical role of Th1-dominant immunity in tumor immunology | |
| P478 | volume | 46 Suppl |
| Q28262548 | Adoptive immunotherapy for cancer: harnessing the T cell response |
| Q37275304 | Adoptive immunotherapy of cancer using CD4(+) T cells |
| Q53640513 | An indispensable role of type-1 IFNs for inducing CTL-mediated complete eradication of established tumor tissue by CpG-liposome co-encapsulated with model tumor antigen |
| Q38948290 | Anti-metastatic study of liposome-encapsulated all trans retinoic acid (ATRA) in B16F10 melanoma cells-implanted C57BL/6 mice |
| Q44078042 | Anti-tumor mechanism of Z-100, an immunomodulatory Arabinomannan extracted from Mycobacterium tuberculosis strain Aoyama B, on pulmonary metastases of B16F10 melanoma: restoration of helper T cell responses via suppression of glucocorticoid-genesis |
| Q40253271 | Antitumor activity of chimeric immunoreceptor gene-modified Tc1 and Th1 cells against autologous carcinoembryonic antigen-expressing colon cancer cells |
| Q40748792 | Application of IL-5 ELISPOT assays to quantification of antigen-specific T helper responses |
| Q36684961 | Avidity of human T cell receptor engineered CD4(+) T cells drives T-helper differentiation fate |
| Q64067972 | Biomaterial-Based Activation and Expansion of Tumor-Specific T Cells |
| Q22241584 | Campbell De Morgan's 'Observations on cancer', and their relevance today |
| Q43253502 | Changes in cytokine and biomarker blood levels in patients with colorectal cancer during dendritic cell-based vaccination |
| Q34658452 | Clinical Implications of Co-Inhibitory Molecule Expression in the Tumor Microenvironment for DC Vaccination: A Game of Stop and Go. |
| Q53411447 | Combination immunotherapy with radiation and CpG-based tumor vaccination for the eradication of radio- and immuno-resistant lung carcinoma cells |
| Q53538331 | Combination tumor immunotherapy with radiotherapy and Th1 cell therapy against murine lung carcinoma |
| Q34842598 | Continuous stress disrupts immunostimulatory effects of IL-12 |
| Q41561252 | DNA vaccination for prostate cancer, from preclinical to clinical trials - where we stand? |
| Q37166167 | Dectin-1-activated dendritic cells trigger potent antitumour immunity through the induction of Th9 cells |
| Q34661797 | Dendritic cell-based vaccines: barriers and opportunities |
| Q36115652 | Dendritic cells in melanoma immunotherapy |
| Q36371068 | Disease-associated bias in T helper type 1 (Th1)/Th2 CD4(+) T cell responses against MAGE-6 in HLA-DRB10401(+) patients with renal cell carcinoma or melanoma |
| Q47839008 | Enhanced cytokine synthesis of leukocytes by a beta-glucan preparation, SCG, extracted from a medicinal mushroom, Sparassis crispa |
| Q40253340 | Gene therapy by membrane-expressed superantigen for alpha-fetoprotein-producing hepatocellular carcinoma |
| Q92156519 | Harnessing the Effects of BTKi on T Cells for Effective Immunotherapy against CLL |
| Q37790599 | Harnessing the immune response to treat cancer |
| Q64377856 | IL-12p70 and IL-18 gene-modified dendritic cells loaded with tumor antigen-derived peptides or recombinant protein effectively stimulate specific Type-1 CD4+ T-cell responses from normal donors and melanoma patients in vitro |
| Q35598991 | Immune checkpoint blockade and interferon-α in melanoma |
| Q37974301 | Immune microenvironmental shift along human colorectal adenoma–carcinoma sequence: is it relevant to tumor development, biomarkers and biotherapeutic targets? |
| Q51610481 | Immunological properties and vaccine efficacy of murine dendritic cells simultaneously expressing melanoma-associated antigen and interleukin-12. |
| Q34567202 | Immunomodulatory activity of Bengkoang (Pachyrhizus erosus) fiber extract in vitro and in vivo |
| Q50457343 | Immunomodulatory effect of tea saponin in immune T-cells and T-lymphoma cells via regulation of Th1, Th2 immune response and MAPK/ERK2 signaling pathway. |
| Q57170853 | Increased CD4 T cell lineage commitment determined by CpG methylation correlates with better prognosis in urinary bladder cancer patients |
| Q50041387 | Induction of Effective Antitumor Response After Mucosal Bacterial Vector Mediated DNA Vaccination With Endogenous Prostate Cancer Specific Antigen |
| Q34448082 | Induction of HCA587-specific antitumor immunity with HCA587 protein formulated with CpG and ISCOM in mice |
| Q36207818 | Influenza virus-like particles engineered by protein transfer with tumor-associated antigens induces protective antitumor immunity. |
| Q74268509 | Interleukin-12-gene transduction makes DCs from tumor-bearing mice an effective inducer of tumor-specific immunity in a peritoneal dissemination model |
| Q51731380 | Interleukin-2 −330T>G Genetic Polymorphism Associates with Prognosis Following Surgery for Thoracic Esophageal Squamous Cell Cancer |
| Q39084378 | Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells |
| Q46319985 | Lenalidomide Enhances the Function of CS1 Chimeric Antigen Receptor-Redirected T Cells Against Multiple Myeloma. |
| Q34980036 | Leukemic dendritic cells: potential for therapy and insights towards immune escape by leukemic blasts |
| Q35224136 | Liposome-encapsulated CpG enhances antitumor activity accompanying the changing of lymphocyte populations in tumor via intratumoral administration |
| Q44512595 | Local Immune Response Predicts Survival in Patients with Thick (T4) Melanomas |
| Q34778175 | Matrix metalloproteinase-2 conditions human dendritic cells to prime inflammatory T(H)2 cells via an IL-12- and OX40L-dependent pathway |
| Q44880897 | Memory T cells protect chicks from acute infectious bronchitis virus infection |
| Q34552898 | Natural killer T (NKT) cells and their role in antitumor immunity. |
| Q35506478 | Natural killer T cell activation overcomes immunosuppression to enhance clearance of postsurgical breast cancer metastasis in mice |
| Q37920836 | Neoadjuvant therapy for high‐risk bulky regional melanoma |
| Q89475629 | Obesity Does Not Exacerbate the Protumorigenic Systemic Environment in Sarcoma Subjects |
| Q36322686 | Plasma membrane vesicles decorated with glycolipid-anchored antigens and adjuvants via protein transfer as an antigen delivery platform for inhibition of tumor growth |
| Q34775164 | Prominent IL-12 production and tumor reduction in athymic nude mice after Toxoplasma gondii lysate antigen treatment |
| Q34468228 | Properties of the mantle cell and mantle cell lymphoma |
| Q39507581 | Prostate stem cell antigen DNA vaccination breaks tolerance to self-antigen and inhibits prostate cancer growth. |
| Q38822157 | Puzzling and ambivalent roles of malarial infections in cancer development and progression |
| Q33276933 | Response of lymphocyte subsets and cytokines to Shenyang prescription in Sprague-Dawley rats with tongue squamous cell carcinomas induced by 4NQO. |
| Q37101727 | ST2 deletion enhances innate and acquired immunity to murine mammary carcinoma |
| Q36174230 | Safety and Efficacy of Combination Immunotherapy With Interferon Alfa-2b and Tremelimumab in Patients With Stage IV Melanoma |
| Q36353361 | Safety and Immunogenicity of Vaccination With MART-1 (26–35, 27L), gp100 (209–217, 210M), and Tyrosinase (368–376, 370D) In Adjuvant With PF-3512676 and GM-CSF In Metastatic Melanoma |
| Q38830870 | Solid-in-oil nanodispersions for transdermal drug delivery systems. |
| Q37045125 | SpecificDioscoreaPhytoextracts Enhance Potency of TCL-Loaded DC-Based Cancer Vaccines |
| Q36106477 | Substrate Rigidity Regulates Human T Cell Activation and Proliferation |
| Q37952806 | TCR-like Biomolecules Target Peptide/MHC Class I Complexes on the Surface of Infected and Cancerous Cells |
| Q44086025 | Th1/Th2 cytokine expression and its relationship with tumor growth in B cell non-Hodgkin's lymphoma (NHL). |
| Q36357944 | Th9 cells promote antitumor immune responses in vivo |
| Q38718460 | The Exportin-1 Inhibitor Selinexor Exerts Superior Antitumor Activity when Combined with T-Cell Checkpoint Inhibitors |
| Q38762581 | The Growth Inhibitory Potential and Antimetastatic Effect of Camel Urine on Breast Cancer Cells In Vitro and In Vivo |
| Q55415383 | The current state and future perspectives of cannabinoids in cancer biology. |
| Q37990783 | The response of human dendritic cells to co-ligation of pattern-recognition receptors. |
| Q35132137 | The role of natural killer T cells and other T cell subsets against infection by the pre-erythrocytic stages of malaria parasites |
| Q44549744 | The trifunctional antibody catumaxomab amplifies and shapes tumor-specific immunity when applied to gastric cancer patients in the adjuvant setting |
| Q37215621 | The use of mycobacterial adjuvant-based agents for immunotherapy of cancer |
| Q38704192 | Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy |
| Q24648032 | Tumor-specific Th17-polarized cells eradicate large established melanoma |
| Q40219738 | Type 1 Immune Mechanisms Driven by the Response to Infection with Attenuated Rabies Virus Result in Changes in the Immune Bias of the Tumor Microenvironment and Necrosis of Mouse GL261 Brain Tumors. |
| Q53414165 | Vitamin E-rich Nanoemulsion Enhances the Antitumor Efficacy of Low-Dose Paclitaxel by Driving Th1 Immune Response |
Search more.